Tiger Brokers

BUZZ-NeoGenomics rises as Medicare covers new cancer blood test

Reuters
Mar 16
BUZZ-<a href="https://laohu8.com/S/NEO">NeoGenomics</a> rises as Medicare covers new cancer blood test

** Shares of cancer testing firm NeoGenomics NEO.O rise 1.1% to $7.97 premarket

** Co says Medicare will now cover its PanTracer LBx blood test

** Test looks for genetic changes linked to cancer, helping doctors pick treatments and clinical trials

** PanTracer LBx checks more than 500 genes and delivers results in about seven days - NEO

** Co says test is run at NeoGenomics’ California lab; co operates labs across the U.S. and the UK

** Shares down ~29% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10